PharmaShots | Incisive News in 3 Shots

Subscribe Now

Luspatercept

BMS's Reblozyl (luspatercept) Receives Health Canada Approval for Beta Thalassemia

BMS's Reblozyl (luspatercept) Receives Health Canada Approval for Beta Thalassemia

September 30, 2020

Celgene and Acceleron Report FDA's Acceptance of BLA for Luspatercept to Treat Myelodysplastic Syndromes and Beta-Thalassemia

Celgene and Acceleron Report FDA's Acceptance of BLA for Luspatercept to Treat Myelodysplastic Syndromes and Beta-Thalassemia

June 4, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us